Skip to main content

LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance.

Publication ,  Journal Article
Elsayes, KM; Kielar, AZ; Chernyak, V; Morshid, A; Furlan, A; Masch, WR; Marks, RM; Kamaya, A; Do, RKG; Kono, Y; Fowler, KJ; Tang, A; Kohli, M ...
Published in: J Hepatocell Carcinoma
2019

The Liver Imaging Reporting and Data System (LI-RADS®) is a comprehensive system for standardizing the terminology, technique, interpretation, reporting, and data collection of liver observations in individuals at high risk for hepatocellular carcinoma (HCC). LI-RADS is supported and endorsed by the American College of Radiology (ACR). Upon its initial release in 2011, LI-RADS applied only to liver observations identified at CT or MRI. It has since been refined and expanded over multiple updates to now also address ultrasound-based surveillance, contrast-enhanced ultrasound for HCC diagnosis, and CT/MRI for assessing treatment response after locoregional therapy. The LI-RADS 2018 version was integrated into the HCC diagnosis, staging, and management practice guidance of the American Association for the Study of Liver Diseases (AASLD). This article reviews the major LI-RADS updates since its 2011 inception and provides an overview of the currently published LI-RADS algorithms.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Hepatocell Carcinoma

DOI

ISSN

2253-5969

Publication Date

2019

Volume

6

Start / End Page

49 / 69

Location

New Zealand
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Elsayes, K. M., Kielar, A. Z., Chernyak, V., Morshid, A., Furlan, A., Masch, W. R., … Sirlin, C. B. (2019). LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance. J Hepatocell Carcinoma, 6, 49–69. https://doi.org/10.2147/JHC.S186239
Elsayes, Khaled M., Ania Z. Kielar, Victoria Chernyak, Ali Morshid, Alessandro Furlan, William R. Masch, Robert M. Marks, et al. “LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance.J Hepatocell Carcinoma 6 (2019): 49–69. https://doi.org/10.2147/JHC.S186239.
Elsayes KM, Kielar AZ, Chernyak V, Morshid A, Furlan A, Masch WR, et al. LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance. J Hepatocell Carcinoma. 2019;6:49–69.
Elsayes, Khaled M., et al. “LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance.J Hepatocell Carcinoma, vol. 6, 2019, pp. 49–69. Pubmed, doi:10.2147/JHC.S186239.
Elsayes KM, Kielar AZ, Chernyak V, Morshid A, Furlan A, Masch WR, Marks RM, Kamaya A, Do RKG, Kono Y, Fowler KJ, Tang A, Bashir MR, Hecht EM, Jambhekar K, Lyshchik A, Rodgers SK, Heiken JP, Kohli M, Fetzer DT, Wilson SR, Kassam Z, Mendiratta-Lala M, Singal AG, Lim CS, Cruite I, Lee J, Ash R, Mitchell DG, McInnes MDF, Sirlin CB. LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance. J Hepatocell Carcinoma. 2019;6:49–69.

Published In

J Hepatocell Carcinoma

DOI

ISSN

2253-5969

Publication Date

2019

Volume

6

Start / End Page

49 / 69

Location

New Zealand